Drugs Made In America Acquisition II Corp. Unit
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DMIIU · as of Jun 9, 2026
Key Statistics
Explore Drugs Made In America Acquisition II Corp. Unit Data
dmiiu stock data · financialsCompetitors & Peers
dmiiu competitorsDMIIU
EIC
GAIN
GAM
MSIF
NCDLStock Performance
Full HistoryAbout Drugs Made In America Acquisition II Corp. Unit
Drugs Made In America Acquisition II Corp. Unit DMIIU is a Special Purpose Acquisition Company (SPAC), operating as a blank check firm established in the Cayman Islands. Its core objective is to identify and complete a merger or acquisition with an…
what is drugs made in america acquisition ii corp. unit · dmiiu stock overview · drugs made in america acquisition ii corp. unit company profile · who is drugs made in america acquisition ii corp. unit ceo · dmiiu NASDAQ · drugs made in america acquisition ii corp. unit headquarters · drugs made in america acquisition ii corp. unit business segments
About Stock Overview & Key Data
Drugs Made In America Acquisition II Corp. Unit (DMIIU) is a Financial Services company in the Asset Management industry, listed on NASDAQ since Sep 25, 2025. As of the latest trading session, DMIIU stock price is $10.22, with a market capitalization of $711.1M. The stock has returned +2.35% over the past 12 months and +2.05% year-to-date.
Frequently Asked Questions
As of the latest trading session, Drugs Made In America Acquisition II Corp. Unit (DMIIU) stock price is $10.22. The stock is traded on NASDAQ under the ticker symbol DMIIU. The 52-week range is $9.94 – $10.80.